At a glance
ClinicalIndex Comparison RecordN/ACompleted· 161 enrolled
Drug / intervention
UR-GOALbehavioral
Likely dose
Not stated in record
Key inclusion· 7
- ✓Patients aged ≥60 years
- ✓Newly diagnosed AML or being worked up for possible AML
- ✓Able to provide informed consent
- ✓Agreement of their oncologist to participate in the study
Key exclusion· 0
None specified.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Randomized Controlled Trial of a Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
In Brief
A clinical study evaluating UR-GOAL for Acute Myeloid Leukemia. Completed, enrolled 161 participants across 1 site.
Detailed Summary
The objective of this study is to evaluate the preliminary efficacy of the UR-GOAL tool in improving shared decision making and communication between older patients with AML and their oncologists in a pilot randomized trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Myeloid Leukemia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedApr 2022
Enrollment StartJun 2022
Primary CompletionApr 2025
Study CompletionOct 2025
TodayJul 2026
First PostedApr 19, 2022
Enrollment StartJun 17, 2022
Primary CompletionApr 7, 2025
Study CompletionOct 6, 2025
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 4.2 years ago
Interventions
UR-GOALbehavioral
UR-GOAL helps conducts assessments of fitness, elicits patient values via Best-Worst Scaling, and elicits preferences for prognostic information and assesses prognostic awareness. The tool also includes an AML educational video.